Old Web
English
Sign In
Acemap
>
authorDetail
>
Steve D. Hatch
Steve D. Hatch
Eli Lilly and Company
Protease
HIV-1 protease
Organic chemistry
Biochemistry
Chemistry
3
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Synthesis and pharmacokinetics of potent carbamate HIV-1 protease inhibitors containing novel high affinity hydroxyethylamine isosteres
1995
Bioorganic & Medicinal Chemistry Letters
William Joseph Hornback
John E. Munroe
Timothy Alan Shepherd
Steve D. Hatch
Mark A. Muesing
MaryAnn Wiskerchen
Joseph M. Colacino
Angela J. Baxter
Kenneth S. Su
Kristina M. Campanale
Show All
Source
Cite
Save
Citations (2)
POTENT, ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITORS CONTAINING NONCODED D-AMINO ACIDS
1995
Bioorganic & Medicinal Chemistry Letters
John E. Munroe
Timothy Alan Shepherd
Louis Nickolaus Jungheim
William Joseph Hornback
Steve D. Hatch
Mark A. Muesing
MaryAnn Wiskerchen
Kenneth S. Su
Kristina M. Campanale
Angela J. Baxter
Joseph M. Colacino
Show All
Source
Cite
Save
Citations (8)
Ly316340: A potent HIV-1 protease inhibitor containing a high affinity octahydrothienopyridine hydroxyethylamine isostere
1995
Bioorganic & Medicinal Chemistry Letters
John E. Munroe
William Joseph Hornback
Jack B. Campbell
Michael A. Ouellette
Steve D. Hatch
Mark A. Muesing
Mary Ann Wiskerchen
Angela J. Baxter
Ken Su
Kristina M. Campanale
Show All
Source
Cite
Save
Citations (6)
1